Literature DB >> 13921808

Leukaemia in Nagasaki atomic bomb survivors from 1945 through 1959.

M TOMONAGA.   

Abstract

This review of the Nagasaki leukaemia experience during a period of 14 years after the detonation of the atomic bomb, together with comparisons with data from Hiroshima and from other series of post-radiation leukaemia cases, again demonstrates beyond reasonable doubt the leukaemogenic effect on man of ionizing radiation. An increased risk of leukaemia following doses probably as low as 100 rads (air-entry dose) of whole-body radiation is demonstrated on the basis of the available estimates of atomic bomb radiation doses. At doses above this level the increase in leukaemia incidence may be linearly related to the radiation dose. The data are too limited to allow of an evaluation of the risk represented by doses at the lower levels of radiation; but it seems clear that, if a threshold dose for leukaemia induction exists, it is lower than the threshold dose for the clinical expression of acute radiation syndrome.The sex and age distribution of radiation-induced leukaemia and the types of leukaemia observed are also discussed.

Entities:  

Keywords:  RADIATION INJURY/complications

Mesh:

Year:  1962        PMID: 13921808      PMCID: PMC2555781     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  Neoplasia in children treated with X-rays in infancy for thymic enlargement.

Authors:  C L SIMPSON; L H HEMPELMANN; L M FULLER
Journal:  Radiology       Date:  1955-06       Impact factor: 11.105

2.  Fetal exposure to diagnostic x rays, and leukemia and other malignant diseases in childhood.

Authors:  D D FORD; J C PATERSON; W L TREUTING
Journal:  J Natl Cancer Inst       Date:  1959-06       Impact factor: 13.506

3.  Radiation dosimetry in Hiroshima and Nagasaki atomic-bomb survivors.

Authors:  E T ARAKAWA
Journal:  N Engl J Med       Date:  1960-09-08       Impact factor: 91.245

4.  Leukemia in children exposed to ionizing radiation.

Authors:  R MURRAY; P HECKEL; L H HEMPELMANN
Journal:  N Engl J Med       Date:  1959-09-17       Impact factor: 91.245

5.  Leukemia in Hiroshima atomic bomb survivors.

Authors:  R HEYSSEL; A B BRILL; L A WOODBURY; E T NISHIMURA; T GHOSE; T HOSHINO; M YAMASAKI
Journal:  Blood       Date:  1960-03       Impact factor: 22.113

6.  Leukemia in Hiroshima City atomic bomb survivors.

Authors:  N WALD
Journal:  Science       Date:  1958-03-28       Impact factor: 47.728

7.  A survey of childhood malignancies.

Authors:  A STEWART; J WEBB; D HEWITT
Journal:  Br Med J       Date:  1958-06-28

8.  Cytologic and biochemical studies on the granulocytes in early leukemia among atomic bomb survivors.

Authors:  W C MOLONEY; R D LANGE
Journal:  Tex Rep Biol Med       Date:  1954

9.  Leukemia in atomic bomb survivors. I. General observations.

Authors:  R D LANGE; W C MOLONEY; T YAMAWAKI
Journal:  Blood       Date:  1954-06       Impact factor: 22.113

10.  Leukemia in atomic bomb survivors. II. Observations on early phases of leukemia.

Authors:  W C MOLONEY; R D LANGE
Journal:  Blood       Date:  1954-07       Impact factor: 22.113

View more
  6 in total

1.  Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation.

Authors:  T Radivoyevitch; R K Sachs; R P Gale; R J Molenaar; D J Brenner; B T Hill; M E Kalaycio; H E Carraway; S Mukherjee; M A Sekeres; J P Maciejewski
Journal:  Leukemia       Date:  2015-09-22       Impact factor: 11.528

Review 2.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

Review 3.  Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review.

Authors:  Leena Rivina; Robert Schiestl
Journal:  Int J Environ Res Public Health       Date:  2012-12-27       Impact factor: 3.390

4.  S-Nitrosylation in Organs of Mice Exposed to Low or High Doses of γ-Rays: The Modulating Effect of Iodine Contrast Agent at a Low Radiation Dose.

Authors:  Fadia Nicolas; Changgong Wu; Salwa Bukhari; Sonia M de Toledo; Hong Li; Masayuki Shibata; Edouard I Azzam
Journal:  Proteomes       Date:  2015-04-28

Review 5.  Radiation-induced myeloid leukemia in murine models.

Authors:  Leena Rivina; Michael Davoren; Robert H Schiestl
Journal:  Hum Genomics       Date:  2014-07-25       Impact factor: 4.639

Review 6.  A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology.

Authors:  Hala Skayneh; Batoul Jishi; Rita Hleihel; Maguy Hamieh; Nadine Darwiche; Ali Bazarbachi; Marwan El Sabban; Hiba El Hajj
Journal:  Genes (Basel)       Date:  2019-08-13       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.